Clinical Trials Browser

Phase NA × Cholangiocarcinoma × 90 days × Clear all

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT02872831 2026-04-13

Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle

Phase NA Withdrawn

Gastrointestinal

Lymphadenopathy, Pancreatic Neoplasms, Cholangiocarcinoma

NCT06910722 2026-04-06

RIS-TH

Phase NA Recruiting

36 enrolled

Gastrointestinal

Cholangiocarcinoma

NCT06971848 2026-03-30

ETCABIO

Phase NA Not yet recruiting

70 enrolled

GastrointestinalLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Immunoglobulin Light-chain Amyloidosis, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Carcinoma, Bronchogenic, Heart Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT06990659 2026-03-11

CHOC

Phase NA Recruiting

206 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Patient Satisfaction, Cholangiocarcinoma

NCT05497531 2026-02-24

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

Phase NA Recruiting

15 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Pancreatic Neoplasms, Cholangiocarcinoma

NCT07224464 2026-02-11

The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.

Phase NA Recruiting

9 enrolled

BreastGastrointestinalGynecologicThoracic

Hyperthermia, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Cholangiocarcinoma

Clinical Trials

LASER

Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle

RIS-TH

ETCABIO

CHOC

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.